Clinical Trial Update: Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating antibacterial prophylaxis in azacitidine-treated patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED